Physician

Sameeksha Bhama, M.D.

According to 2025 Medicare claims, Sameeksha Bhama, M.D. (NPI: 1699018234) practices hematology/oncology in the Dallas-Plano-Irving, TX market, with the plurality of this provider's patient population coming from Collin, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1811944101; TIN: 752131429) and primary practice location at 75035-0522.

Bhama's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 243 traditional Medicare patients, billed 96,242 HCPCS/CPT codes, and received $1,642,425 in Medicare payments. The top billing code was 96365 (Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less). Part D data shows 278 prescription claims across 81 beneficiaries totaling $470,047 in drug costs, led by Calquence (Acalabrutinib Maleate). Open Payments data shows 71 records totaling $2,215. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $3,509 to $1,642,425. Similarly, Part D prescription costs have risen steadily, from $2,084 to $470,047. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$821K$1.6M2016 Medicare payment: $3,509 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $4,887 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $5,064 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $28,384 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $35,376 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $15,506 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,642,425 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
20161643$3,509
20172946$4,887
2018N/RN/RN/R
2019N/RN/RN/R
20202955$5,064
2021112314$28,384
202292437$35,376
202376180$15,506
202424396,242$1,642,425

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$502K$1.0M2015 Drug cost: $2,084 (USD; Tot_Drug_Cst)2016 Drug cost: $13,241 (USD; Tot_Drug_Cst)2017 Drug cost: $5,291 (USD; Tot_Drug_Cst)2018 Drug cost: $122,680 (USD; Tot_Drug_Cst)2019 Drug cost: $30,717 (USD; Tot_Drug_Cst)2020 Drug cost: $14,602 (USD; Tot_Drug_Cst)2021 Drug cost: $174,370 (USD; Tot_Drug_Cst)2022 Drug cost: $821,948 (USD; Tot_Drug_Cst)2023 Drug cost: $1,004,834 (USD; Tot_Drug_Cst)2024 Drug cost: $470,047 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152277$2,084
201623109$13,241
20171872$5,291
20182878$122,680
201947145$30,717
202037120$14,602
202175374$174,370
2022121552$821,948
2023113626$1,004,834
202481278$470,047

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
96365Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less62145$46
96375Injection of additional new drug or substance into vein58236$11
80053Blood test, comprehensive group of blood chemicals64245$10
36415Insertion of needle into vein for collection of blood sample74378$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count75324$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
CalquenceAcalabrutinib Maleate16480$223,167
AnastrozoleAnastrozole312,250$531
Ondansetron OdtOndansetron12330$474
Levothyroxine SodiumLevothyroxine Sodium11580$63
Pantoprazole SodiumPantoprazole Sodium11615$46

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.71$2,215Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Sameeksha Bhama, M.D.?

Tedicare shows public-source Medicare data for Sameeksha Bhama, M.D. (NPI 1699018234), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sameeksha Bhama, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Sameeksha Bhama, M.D.?

Sameeksha Bhama, M.D. is linked to TEXAS ONCOLOGY PA (billing NPI 1811944101) in the available physician profile data.

Does Sameeksha Bhama, M.D. have Open Payments data?

Sameeksha Bhama, M.D. has 71 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.